U.S. market Closed. Opens in 6 hours 25 minutes

CYTK | Cytokinetics, Incorporated Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
Revenue7.53M94.59M70.43M55.83M26.87M31.50M13.37M106.41M28.66M46.94M30.65M7.56M4.00M2.58M81.54M12.42M13.62M3.13M8.91M13.44M10.58M11.40M8.47MN/A
Cost of Revenue330.12M240.81M159.94M96.95M86.12M89.14M90.30M59.90M46.40M44.43M49.45M35.00MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-322.59M-146.22M-89.51M-41.12M-59.26M-57.63M-76.93M46.51M-17.74M2.51M-18.80M-27.44M4.00M2.58M81.54M12.42M13.62M3.13M8.91M13.44M10.58M11.40M8.47MN/A
Operating Expenses173.61M177.98M96.80M52.82M39.61M31.28M36.47M27.82M19.67M17.27M15.09M11.72M50.77M52.21M55.47M69.03M70.11M64.47M53.55M51.88M43.17M35.38M26.86M13.79M
Selling, General & Admin173.61M177.98M96.80M52.82M39.61M31.28M36.47M27.82M19.67M17.27M15.09M11.72M13.59M14.20M15.63M15.08M16.72M15.24M12.97M11.99M9.16M6.95M5.90M3.39M
Research & DevelopmentN/A6.59M159.94M96.95M86.12M89.14M90.30M59.90M46.40M44.43M49.45M35.00M37.18M38.01M39.84M53.95M53.39M49.23M40.57M39.88M34.00M28.42M20.96M10.40M
Other Operating ExpensesN/A-6.59M-159.94M-96.95M-86.12MN/AN/A58.66M31.73M24.89M47.43M31.41M36.32M36.53M32.65M56.24M52.00M47.60M35.59M30.55MN/AN/AN/AN/A
Operating Income-496.20M-324.20M-186.31M-93.94M-98.87M-88.92M-113.40M18.69M-37.41M-14.75M-33.89M-39.10M-47.96M-49.63M26.09M-59.08M-56.49M-61.34M-44.63M-38.43M-32.59M-23.98M-18.39M-13.79M
Other Expenses / Income-30.04M-64.75M-29.00M-33.35M-22.82M-17.37M-14.39M-2.23M-94.00K108.00K177.00K87.00K104.00K172.00K-1.40M232.00K7.59M4.22M2.38M1.24MN/AN/A18.39MN/A
Before Tax Income-526.24M-388.95M-215.31M-127.29M-121.69M-106.29M-127.79M16.45M-37.50M-14.65M-33.72M-39.02M-47.86M-49.46M24.69M-56.37M-48.89M-57.12M-42.25M-37.20MN/AN/AN/AN/A
Income Tax ExpensesN/A13.60M27.06M36.84M27.36M4.19M682.00K-741.00K-589.00K-490.00K-433.00K-678.00K-209.00K-176.00K150.00K-232.00KN/AN/AN/AN/A95.00K-901.00K15.87M13.08M
Net Income-526.24M-402.55M-242.37M-164.13M-149.05M-106.29M-127.79M16.45M-37.50M-14.65M-33.72M-39.02M-47.86M-49.29M24.54M-56.37M-48.89M-57.12M-42.25M-37.20M-32.69M-23.08M-15.87M-13.08M
Interest Expenses57.67M51.16M29.33M38.68M27.36M21.56M17.00M2.23M94.00KN/AN/A2.00K104.00K163.00K409.00K491.00K699.00K523.00K535.00K549.00K2.49M1.33M438.00K267.00K
Basic Shares Outstanding96.52M89.83M76.89M64.52M57.58M54.42M49.40M39.94M38.66M35.71M27.27M18.11M11.80M10.69M9.57M8.23M7.93M6.10M4.76M3.30M318.50K290.33K236.64K160.87K
Diluted Shares Outstanding96.52M89.83M76.89M64.52M57.58M54.42M49.40M42.56M38.81M35.71M27.27M18.11M11.80M10.69M9.66M8.23M7.93M6.10M4.76M3.30M318.57K290.33K236.64K160.87K
EBITDA-456.68M-329.40M-176.34M-86.78M-93.04M-83.49M-108.89M14.93M-36.66M-14.16M-33.28M-39.78M-46.52M-47.40M27.12M-53.43M-45.37M-53.66M-38.68M-33.39M-29.41M-21.13M-18.39M-13.79M
EBITDA Margin-6,064.86%-348.25%-250.39%-155.45%-346.28%-265.03%-814.59%14.03%-127.93%-30.16%-108.60%-526.22%-1,163.10%-1,839.35%33.27%-430.17%-333.03%-1,715.93%-434.03%-248.38%-278.05%-185.43%-217.25%0.00%
EBIT-468.58M-337.80M-185.98M-88.61M-94.33M-80.53M-110.11M17.95M-38.00M-15.14M-34.15M-39.69M-47.97M-49.30M25.10M-56.12M-48.20M-56.59M-41.72M-36.65M-30.10M-22.65M438.00K267.00K
EBIT Margin-6,222.79%-357.13%-264.07%-158.73%-351.09%-255.66%-823.70%16.87%-132.58%-32.25%-111.43%-525.08%-1,199.13%-1,913.08%30.79%-451.81%-353.80%-1,809.79%-468.10%-272.65%-284.58%-198.75%5.17%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙